Procurement of Medical Injectables and Vaccines for Indian Navy
Indian Navy · Healthcare Services · open
Key facts
- Published: 22 Jul 2026
- Closing date: 01 Aug 2026
- Status: open
- Ministry: Ministry of Defence
- Department: Department of Military Affairs
Description
Tender for supply of various medical injectables including Propofol, Ephedrine, Betamethasone, Dexamethasone, Methylene Blue, Adenosine, Metoclopramide, Ceftriaxone, Hepatitis B Vaccine, and Rabies Immunoglobulin, with a total quantity of 2770 units, for Indian Navy under the Ministry of Defence. The bid validity is 180 days from the end date, with bid opening scheduled for 01-08-2026 at 10:30 AM.
Eligibility & requirements
- Startup relaxation: Yes
- MSE relaxation: Yes
- Documents required: Experience certificate, Turnover proof, OEM authorization, BoQ compliance documents
Commercial terms
- Bid type: Two Packet Bid
- Evaluation: wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (10)
- Propofol 1 percent OR 10mg per ml, 20 ml Inj — Qty: 2770 ml
- Ephedrine Hydrochloride 30mg per ml Inj — Qty: 2770 ml
- Betamethasone 4 mg, 1ml Inj — Qty: 2770 ml
- Dexamethasone Sodium Phosphate 4.4 mg Eq to Dexamethosone Phosphate 4mg per ml, 2ml Inj — Qty: 2770 ml
- Methylene Blue 1 percentage, 10 mg per ml, Amp of 10 ml — Qty: 2770 ml
- Adenosine 3 mg per ml, 10 ml Inj — Qty: 2770 ml
- Metoclopramide HCl 5mg per ml, 2ml Inj — Qty: 2770 ml
- Ceftriaxone 1 gm Inj — Qty: 2770 gm
- Hepatitis B Vaccine — Qty: 2770
- Human Rabies Immune Globulin 150 IU per ml, 2 ml Vial — Qty: 2770 ml
1 tender document(s) available — sign up to download.